ProfileGDS4718 / 217903_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 77% 74% 77% 70% 73% 68% 76% 73% 74% 73% 73% 75% 71% 72% 73% 72% 72% 68% 74% 77% 72% 71% 76% 71% 74% 75% 72% 73% 71% 74% 78% 79% 75% 65% 69% 73% 75% 75% 72% 75% 66% 67% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0421172
GSM549102patient 115, normal, homogenized [OPG study]7.4828677
GSM549104patient 119, normal, homogenized [OPG study]7.2990574
GSM549108patient 138, normal, homogenized [OPG study]7.4094777
GSM549119patient 077, normal, homogenized [OPG study]6.8818270
GSM549133patient 032, cancer, homogenized [OPG study]7.1949573
GSM549139patient 042, cancer, homogenized [OPG study]6.7527968
GSM549099patient 107, normal, homogenized [OPG study]7.3563776
GSM549109patient 139, normal, homogenized [OPG study]7.1153473
GSM549110patient 046, normal, homogenized [OPG study]7.1579774
GSM549114patient 063, normal, homogenized [OPG study]7.1864773
GSM549122patient 082, normal, homogenized [OPG study]7.1313773
GSM549134patient 033, cancer, homogenized [OPG study]7.3157775
GSM549136patient 036, cancer, homogenized [OPG study]7.0469371
GSM549140patient 044, cancer, homogenized [OPG study]7.0564972
GSM549111patient 047, normal, homogenized [OPG study]7.1421273
GSM549113patient 057, normal, homogenized [OPG study]7.0780172
GSM549132patient 031, cancer, homogenized [OPG study]7.0950372
GSM549137patient 038, cancer, homogenized [OPG study]6.7622468
GSM549142patient 047, cancer, homogenized [OPG study]7.1338474
GSM549100patient 110, normal, homogenized [OPG study]7.4234977
GSM549107patient 135, normal, homogenized [OPG study]7.0161272
GSM549115patient 068, normal, homogenized [OPG study]7.0032571
GSM549116patient 072, normal, homogenized [OPG study]7.4453376
GSM549120patient 078, normal, homogenized [OPG study]6.9307271
GSM549131patient 030, cancer, homogenized [OPG study]7.3233374
GSM549118patient 074, normal, homogenized [OPG study]7.3542275
GSM549129patient 027, cancer, homogenized [OPG study]7.1113972
GSM549123patient 088, normal, homogenized [OPG study]7.1335573
GSM549124patient 006, cancer, homogenized [OPG study]6.8923271
GSM549126patient 015, cancer, homogenized [OPG study]7.2119274
GSM549128patient 025, cancer, homogenized [OPG study]7.7309978
GSM549103patient 117, normal, homogenized [OPG study]7.6248879
GSM549117patient 073, normal, homogenized [OPG study]7.2928275
GSM549138patient 041, cancer, homogenized [OPG study]6.4935765
GSM549141patient 045, cancer, homogenized [OPG study]6.8232569
GSM549130patient 028, cancer, homogenized [OPG study]7.0903673
GSM549101patient 111, normal, homogenized [OPG study]7.3383275
GSM549105patient 128, normal, homogenized [OPG study]7.3108575
GSM549106patient 134, normal, homogenized [OPG study]7.1757972
GSM549112patient 048, normal, homogenized [OPG study]7.326875
GSM549125patient 011, cancer, homogenized [OPG study]6.5804266
GSM549127patient 024, cancer, homogenized [OPG study]6.7215967
GSM549135patient 035, cancer, homogenized [OPG study]7.1348172